title: The maternal HLA-G 1597ΔC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women.
abstract: The non-classical major histocompatibility complex molecule, human leukocyte antigen (HLA)-G, is thought to contribute to maternal immune tolerance and successful placentation during pregnancy. Genetic polymorphisms in HLA-G are known to influence expression levels as well as the relative expression of individual protein isoforms. As diminished or aberrant HLA-G expression patterns may contribute to the development of certain pregnancy complications, we sought to investigate the association between functional HLA-G polymorphisms and the risk of pre-eclampsia (PE) in African-American women. The association between maternal and fetal genotype at six HLA-G polymorphisms and risk of PE was assessed in 372 pregnancies (314 normotensive; 58 pre-eclamptic). We observed an elevated risk of PE (P = 0.00027) in pregnancies where the mother carried the 1597ΔC allele, a null allele that abolishes expression of full-length HLA-G isoforms. Furthermore, the frequency of the maternal 1597ΔC allele was highest in the subset of pre-eclamptic pregnancies that were delivered preterm, suggesting an association between the null allele and the severity of PE. We then replicated the association between higher maternal 1597ΔC allele frequency and increased severity of PE (P = 0.038) in an independent sample of 533 African-American women. Finally, to investigate the mechanistic basis of this association, we measured circulating soluble HLA-G (sHLA-G) concentrations in maternal serum collected during pregnancy in 51 healthy, normotensive African-American control women and found significantly lower levels in women carrying the 1597ΔC allele (P = 0.012). These results demonstrate that maternal HLA-G genotype is significantly associated with risk of PE in African-American women and is predictive of circulating sHLA-G levels during pregnancy.
authors.affiliation: Department of Human Genetics,  The University of Chicago, 920 E 58th St., Chicago, IL 60637,  USA.
authors.forename: Dagan A
authors.initials: DA
authors.lastname: Loisel
authors.forename: Christine
authors.initials: C
authors.lastname: Billstrand
authors.forename: Kathleen
authors.initials: K
authors.lastname: Murray
authors.forename: Kristen
authors.initials: K
authors.lastname: Patterson
authors.forename: Tinnakorn
authors.initials: T
authors.lastname: Chaiworapongsa
authors.forename: Roberto
authors.initials: R
authors.lastname: Romero
authors.forename: Carole
authors.initials: C
authors.lastname: Ober
mesh_terms: D000328:Adult; D001741:Black or African American; D000483:Alleles; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D005260:Female; D017353:Gene Deletion; D005786:Gene Expression Regulation; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D059951:HLA-G Antigens / Q000097:blood / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D011110:Polymorphism, Genetic; D011225:Pre-Eclampsia / Q000097:blood / Q000208:ethnology* / Q000235:genetics*; D011247:Pregnancy; D012306:Risk; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D059951:HLA-G Antigens